Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1949 3
1950 11
1951 5
1952 1
1954 1
1955 1
1958 3
1961 1
1965 2
1966 3
1967 3
1968 1
1969 1
1971 1
1976 1
1979 2
1980 1
1981 2
1984 2
1986 1
1991 1
1993 2
1994 1
1995 1
1997 3
1998 1
2000 4
2002 2
2003 1
2005 1
2006 2
2007 2
2009 1
2011 1
2012 1
2013 1
2014 2
2015 3
2016 2
2017 1
2020 4
2021 2
2022 4
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer.
Belluomini L, Avancini A, Sposito M, Milella M, Rossi A, Pilotto S. Belluomini L, et al. Among authors: sposito m. Expert Opin Biol Ther. 2023 Jul-Dec;23(11):1077-1087. doi: 10.1080/14712598.2023.2198087. Epub 2023 Apr 3. Expert Opin Biol Ther. 2023. PMID: 36995069 Review.
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories.
Sposito M, Belluomini L, Pontolillo L, Tregnago D, Trestini I, Insolda J, Avancini A, Milella M, Bria E, Carbognin L, Pilotto S. Sposito M, et al. J Pers Med. 2023 Sep 22;13(10):1427. doi: 10.3390/jpm13101427. J Pers Med. 2023. PMID: 37888038 Free PMC article. Review.
Exercise and Bone Health in Cancer: Enemy or Ally?
Avancini A, Benato G, Borsati A, Oliviero L, Belluomini L, Sposito M, Tregnago D, Trestini I, Insolda J, Zacchi F, Fiorio E, Schena F, Milella M, Pilotto S. Avancini A, et al. Among authors: sposito m. Cancers (Basel). 2022 Dec 10;14(24):6078. doi: 10.3390/cancers14246078. Cancers (Basel). 2022. PMID: 36551564 Free PMC article. Review.
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors.
Ferrara MG, Belluomini L, Smimmo A, Sposito M, Avancini A, Giannarelli D, Milella M, Pilotto S, Bria E. Ferrara MG, et al. Among authors: sposito m. Crit Rev Oncol Hematol. 2023 Apr;184:103929. doi: 10.1016/j.critrevonc.2023.103929. Epub 2023 Feb 10. Crit Rev Oncol Hematol. 2023. PMID: 36773668 Free article. Review.
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
Belluomini L, Caldart A, Avancini A, Dodi A, Trestini I, Kadrija D, Sposito M, Tregnago D, Casali M, Riva ST, Sartori G, Menis J, Milella M, Pilotto S. Belluomini L, et al. Among authors: sposito m. Int J Mol Sci. 2020 Dec 22;22(1):42. doi: 10.3390/ijms22010042. Int J Mol Sci. 2020. PMID: 33375194 Free PMC article. Review.
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients.
Adamo A, Frusteri C, Pilotto S, Caligola S, Belluomini L, Poffe O, Giacobazzi L, Dusi S, Musiu C, Hu Y, Wang T, Rizzini D, Vella A, Canè S, Sartori G, Insolda J, Sposito M, Incani UC, Carbone C, Piro G, Pettinella F, Qi F, Wang D, Sartoris S, De Sanctis F, Scapini P, Dusi S, Cassatella MA, Bria E, Milella M, Bronte V, Ugel S. Adamo A, et al. Among authors: sposito m. Oncoimmunology. 2023 Sep 14;12(1):2253644. doi: 10.1080/2162402X.2023.2253644. eCollection 2023. Oncoimmunology. 2023. PMID: 37720688 Free PMC article.
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review.
Del Bianco N, Borsati A, Toniolo L, Ciurnielli C, Belluomini L, Insolda J, Sposito M, Milella M, Schena F, Pilotto S, Avancini A. Del Bianco N, et al. Among authors: sposito m. Crit Rev Oncol Hematol. 2024 Apr 18;198:104350. doi: 10.1016/j.critrevonc.2024.104350. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 38642726 Free article. Review.
105 results